Molteni Farmaceutici Plans For EU Entry Of Titan’s Six-Month Buprenorphine Implant

 
• By John Davis

Molteni Farmaceutici/Titan’s Sixmo, the first six-month buprenorphine implant just approved for EU marketing, could be a valued option for a sizeable number of patients.  

Poppy
Opiates from the poppy are highly addictive psychoactive agents • Source: Shutterstock

More from New Products

More from Scrip